News 22.03.18

Prexton Therapeutics acquired by Lundbeck

H. Lundbeck A/S (Lundbeck) and Prexton Therapeutics BV (Prexton) announced March 16th the signing of a definitive agreement in which Lundbeck will acquire Prexton.

Read more
News 14.03.18

Ardena acquires ChemConnection adding API expertise

Contract development and manufacturing organisation (CDMO) Ardena has acquired ChemConnection.

Read more
News 13.03.18

InProcess-LSP ontvangt financiering voor nieuwe testtechniek ‘nanomedicijnen’

Life sciences-start-up InProcess-LSP haalt een investering op bij de Brabantse Ontwikkelings Maatschappij (BOM) voor de verdere ontwikkeling van de NanoFlowSizer.

Read more
News 07.03.18

Aduro Announces Milestone Achieved under Merck Collaboration for Initiation of Anti-CD27 Phase I Trial in Advanced Solid Tumors

Aduro Biotech announced that the company earned a $3.0 million development milestone payment under its worldwide licensing agreement with Merck for the initiation of a Phase I clinical trial of its anti-CD27 antibody.

Read more
News 01.03.18

Brigitte Drees nieuwe directeur Pivot Park

Brigitte Drees volgt Mirjam Mol-Arts op, welke 1 januari afscheid nam van het Pivot Park.

Read more
News 27.02.18

RA2day: addressing today’s regulatory topics

Zwiers Regulatory Consultancy is organising RA2day on April 13th 2018.

Read more
News 08.02.18

Over 50 companies based at Pivot Park!

Recently the number of companies based at Pivot Park reached the milestone of 50!

Read more
News 08.02.18

New at Pivot Park – PharmaCytics

PharmaCytics offers a drug delivery solution, based on an advanced prodrug approach.

Read more
News 25.01.18

InnatOss and MediSapiens Receive EU Grant to Personalize Lyme Diagnostics

Recently the number of companies based at Pivot Park reached the milestone of 50!

Read more